Skip to main content
Prasanna Jagannathan, MD, Infectious Disease, Stanford, CA

PrasannaJagannathanMD

Infectious Disease • Stanford, CA

Assistant Professor, Medicine, University of California, San Francisco, School of

Join to view full profile

Dr. Jagannathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jagannathan's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
  • Harvard Medical School
    Harvard Medical SchoolClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria During Pregnancy and Risk of Malaria in Early Childhood: A Randomized Controlled Trial  
    Bryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One

Press Mentions

  • Women Are at Much Higher Risk of Long COVID Than Men. Why?
    Women Are at Much Higher Risk of Long COVID Than Men. Why?March 25th, 2025
  • I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?
    I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?September 5th, 2022
  • Paxlovid for COVID-19: Important Information
    Paxlovid for COVID-19: Important InformationJuly 14th, 2022
  • Join now to see all

Grant Support

  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
  • Computational models of naturally acquired immunity to falciparum malariaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025

Dr. Prasanna Jagannathan, Dr. Prasanna Jagannathan, MD, Dr. P Jagannathan